Introducing ‘BYOP’ clinical trials

BYOD — “bring your own device” — became a common term in tech circles a decade ago. Now with primary care doctors playing a growing role in clinical trials, the provider of decentralized clinical research software Curebase (San Francisco) aims to popularize the concept of “BYOP” — “bring your own physician.” That is, the company is working to connect patients with local physicians to collect real-world data and execute trials.

In any event, decentralized and hybrid clinical trials continue to gain ground as the pandemic persists. The trend is elevating the role of community-based clinical trials in areas such as oncology.

Additionally, physicians are playing a growing role in spurring clinical trial recruitment, according to a recent survey from Informa Pharma Intelligence and Rare Patient Voice. Almost half (48%) of patients taking part in a clinical trial had first learned of the opportunity from their physician. Among those who had not participated in a clinical trial, 81% said they would be more likely to participate if their physicians informed them of a possibility of enrolling.

“We have multiple clinical trials right now where patients can participate with their own doctor,” said Tom Lemberg, CEO of Curebase.

One of those trials enables expectant mothers across the country to join a clinical trial. Whereas similar studies in the past would have required patients to visit a local academic medical center to participate, the trial enables women to go to their local doctor. “They can go to their own OB-GYN physician for their normal second- and third-trimester visits, and we can collect data at the point of care,” Lemberg said.

Decentralized studies don’t necessarily mean “clinical trials from your couch,” Lemberg said. Enabling doctors outside of academic medical centers to play an integral role in clinical trials is “the next big step to realize the full potential,” he added.

In 2020, the clinical trials market was worth $44.3 billion in 2020, according to Grand View Research. Decentralized clinical trials make up a growing slice of the market, thanks in large part to the pandemic. “COVID really forced pharmaceutical companies and regulators to invest in this method,” Lemberg said.

One of CureBase’s customers, InBios International Inc., won emergency use authorization for its SCoV-2 Ag Detect rapid SARS-CoV-2 test. The clinical data InBios filed with FDA was based on a decentralized clinical trial. That study drew data from COVID-19 drive-through testing and clinic-based sites.

“We turned ordinary healthcare providers into researchers,” Lemberg said. “These were not traditional research sites. They were just COVID testing clinics that we activated to form our research network.”

Although fully decentralized clinical trials are not always feasible, they offer several advantages. In addition to reducing COVID-19 transmission risks, they can also help “achieve greater diversity, access to more patients in different demographic groups, socioeconomic groups, racial groups, etc.,” Lemberg said.

Media contact:
media@curebase.com

Related Links:

Original Article

SOURCE Drug Discover Trends

https://www.curebase.com

Press Releases

See More

Article Title

It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing.

Entire article

Article Title

It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing.

Entire article

Remote Care Powered CURE-19 Platform Enables At Home COVID-19 Clinical Trials

Curebase launches the CURE-19 Platform to provide a resource for researchers seeking to better understand COVID-19 as the pandemic begins

Entire article

Curebase Secures Jane Myles as Vice President of Clinical Trial Innovation

Curebase, a company committed to democratizing access to clinical studies through decentralized clinical trials, has named tenured clinical research expert Jane Myles as vice president of clinical trial innovation

Entire article

Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay

NEW YORK – Cofactor Genomics said Tuesday that it has commenced the first multicenter clinical trial of its OncoPrism immunotherapy response prediction assay, an RNA-based test developed using the company's proprietary immune modeling technology.

Entire article

Startups Cash In as Venture Funding for Digital Health Rises

The success of Doximity, which went public in June and now has a market capitalization around $8.87 billion, and other digital-health startups have encouraged venture investment.

Entire article

Preliminary Outcomes of a Digital Therapeutic Intervention for Smoking Cessation in Adult Smokers: Randomized Controlled Trial

Tobacco smoking remains the leading cause of preventable death and disease worldwide. Digital interventions delivered through smartphones offer a promising alternative to traditional methods, but little is known about their effectiveness.

Entire article

CLM tests drug plus digital combo for high blood pressure

UK biotech Closed Loop Medicine (CLM) has started recruiting patients into a trial that will test whether a drug linked to a smartphone app can improve treatment for hypertension.

Entire article

Non-Traditional Clinical Trial Sites Powered by the Curebase System Support Emergency Use Authorization of New Rapid COVID-19 Test

Operationalizing drive-through COVID testing locations as clinical research sites provided a safe and convenient way to enroll and consent potential participants in key diagnostic validation study

Entire article

Curebase, InBios Announce Results of Virtual Clinical Trial of InBios COVID-19 Rapid Detection Test Using Curebase Platform

Study demonstrates efficacy of InBios diagnostics test, Curebase decentralized trials platform

Entire article

Curebase Names Paul Donnelly as Senior Vice President of Enterprise Strategy

Industry veteran brings more than two decades of success building healthcare companies

Entire article

Curebase nabs $15M for siteless trials that revolve 'around the patient's lifestyle'

Curebase has raised a $15 million series A for a new approach to decentralized trials that goes beyond the current drop of virtual trial platforms.

Entire article

Curebase, Adaptive Biotechnologies Announce Collaboration to Expand Clinical Study Access

Initial study will validate effectiveness of Adaptive's Lyme disease immune detection test

Entire article

Press Releases

See more

Introducing ‘BYOP’ clinical trials

The company Curebase is promoting the concept of 'bring-your-own-physician' clinical trials.

Entire article

Curebase Names Paul Donnelly as Senior Vice President of Enterprise Strategy

Industry veteran brings more than two decades of success building healthcare companies

Entire article

Startups Cash In as Venture Funding for Digital Health Rises

The success of Doximity, which went public in June and now has a market capitalization around $8.87 billion, and other digital-health startups have encouraged venture investment.

Entire article

Curebase, InBios Announce Results of Virtual Clinical Trial of InBios COVID-19 Rapid Detection Test Using Curebase Platform

Study demonstrates efficacy of InBios diagnostics test, Curebase decentralized trials platform

Entire article

Curebase nabs $15M for siteless trials that revolve 'around the patient's lifestyle'

Curebase has raised a $15 million series A for a new approach to decentralized trials that goes beyond the current drop of virtual trial platforms.

Entire article

Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay

NEW YORK – Cofactor Genomics said Tuesday that it has commenced the first multicenter clinical trial of its Onco Prism immunotherapy response prediction assay, an RNA-based test developed using the company's proprietary immune modeling technology.

Entire article

Non-Traditional Clinical Trial Sites Powered by the Curebase System Support Emergency Use Authorization of New Rapid COVID-19 Test

Operationalizing drive-through COVID testing locations as clinical research sites provided a safe and convenient way to enroll and consent potential participants in key diagnostic validation study

Entire article

CLM tests drug plus digital combo for high blood pressure

UK biotech Closed Loop Medicine (CLM) has started recruiting patients into a trial that will test whether a drug linked to a smartphone app can improve treatment for hypertension.

Entire article

Preliminary Outcomes of a Digital Therapeutic Intervention for Smoking Cessation in Adult Smokers: Randomized Controlled Trial

Tobacco smoking remains the leading cause of preventable death and disease worldwide. Digital interventions delivered through smartphones offer a promising alternative to traditional methods, but little is known about their effectiveness.

Entire article

Curebase Secures Jane Myles as Vice President of Clinical Trial Innovation

Curebase, a company committed to democratizing access to clinical studies through decentralized clinical trials, has named tenured clinical research expert Jane Myles as vice president of clinical trial innovation

Entire article

Curebase, Adaptive Biotechnologies Announce Collaboration to Expand Clinical Study Access

Initial study will validate effectiveness of Adaptive's Lyme disease immune detection test

Entire article

Introducing ‘BYOP’ clinical trials

The company Curebase is promoting the concept of 'bring-your-own-physician' clinical trials.

Entire article

Curebase Names Paul Donnelly as Senior Vice President of Enterprise Strategy

Industry veteran brings more than two decades of success building healthcare companies

Entire article

Startups Cash In as Venture Funding for Digital Health Rises

The success of Doximity, which went public in June and now has a market capitalization around $8.87 billion, and other digital-health startups have encouraged venture investment.

Entire article

Curebase, InBios Announce Results of Virtual Clinical Trial of InBios COVID-19 Rapid Detection Test Using Curebase Platform

Study demonstrates efficacy of InBios diagnostics test, Curebase decentralized trials platform

Entire article

Curebase nabs $15M for siteless trials that revolve 'around the patient's lifestyle'

Curebase has raised a $15 million series A for a new approach to decentralized trials that goes beyond the current drop of virtual trial platforms.

Entire article

Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay

NEW YORK – Cofactor Genomics said Tuesday that it has commenced the first multicenter clinical trial of its OncoPrism immunotherapy response prediction assay, an RNA-based test developed using the company's proprietary immune modeling technology.

Entire article

Non-Traditional Clinical Trial Sites Powered by the Curebase System Support Emergency Use Authorization of New Rapid COVID-19 Test

Operationalizing drive-through COVID testing locations as clinical research sites provided a safe and convenient way to enroll and consent potential participants in key diagnostic validation study

Entire article

CLM tests drug plus digital combo for high blood pressure

UK biotech Closed Loop Medicine (CLM) has started recruiting patients into a trial that will test whether a drug linked to a smartphone app can improve treatment for hypertension.

Entire article

Preliminary Outcomes of a Digital Therapeutic Intervention for Smoking Cessation in Adult Smokers: Randomized Controlled Trial

Tobacco smoking remains the leading cause of preventable death and disease worldwide. Digital interventions delivered through smartphones offer a promising alternative to traditional methods, but little is known about their effectiveness.

Entire article

Remote Care Powered CURE-19 Platform Enables At Home COVID-19 Clinical Trials

Curebase launches the CURE-19 Platform to provide a resource for researchers seeking to better understand COVID-19 as the pandemic begins

Entire article

Our latest news

It was popularised in the 1960s with the release of Letraset sheets containing Lorem Ipsum passages, and more recently with desktop publishing software like Aldus PageMaker including versions of Lorem Ipsum.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
335 S Van Ness Ave, San Francisco, CA,
94103-3627, United States